Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Jess, you missed my point:
AUPH has been bouncing since FDA approval, when it goes over 15, I sell a small position when it goes down in the 12-13 range , I buy it back, total no brainer since It happens so often. When the stock goes above 15 and stays there, I”ll be done flipping.
Instead of complaining , I’m adding to my position, with no money out of pocket ……..by the way, it just happened again today.
With everything going on, all the biotechs are dancing around, look at SRNE it’s the same boat.
Good point Zzat, that’s why you only flip 10% of your position. Bio stocks are extremely volatile before they head north permanently , and trust me it really breaks the monotony of just waiting.
Meant: This AUPH ride- mid to low teens swing- will be going on for at least a few more weeks.The only way to navigate your long term position is to sell a small portion when it hits 15 and buy it back when it dips to 12–13.
Another Seeking Alpha analyst who gets it.
Nice Greg!
If you can’t beat em’, buy em’.
Cosa, good to see you on this board, MRNS - like AUPH - is primed to pop.
It’s gonna be Glasko
But he’s right and that’s all that matters.
You’re qoutin’ me Smalls ……not Killin’ me just qoutin’.
Finally, A SPOT ON AUPH analysis!!
I couldn’t have written the article better myself….
Replying again, just to make sure he does,
This will hit 40+ very soon
Absolutely
Slim, where ya been?
And a few more the prior day
Much more than that
Exactly!!
Likewise Dart, smart move.
Jess is echoing something I’ve been saying for over a year on this board.AUPH’s only drug is Voclosporin, sales generation and solid balance sheets will be the catalyst……in the meantime, we hope for a BO and Glaxo makes the most sense. The only problem with current sales being under a million per quarter, the amount of the BO could be as low as 35-40, instead of the 60-70 I was expecting.
Either way, this stock at least triples by Q3.
Wainwright just updated their 35 PT and Cantor Fitzgerald just raised to 34.
I’m amazed by the amount of posters here that expected a huge pop after just 3 months of new sales during a pandemic.
This stock is an absolute steal right now, that conference call had more positive news than negative.
It’s time to double down, don’t wait
They normally announce after close
Peter’s right about this.
With their hat officially in the covid ring, expect more days like today.
That’s how it’s done .....this stock used to be a great flipper last year, but I believe it’s on the rise indefinitely now.
Anyone else own COCP?
..., it’s on the rise
Selling at 2 bucks??
Have faith and hang on, this news will travel more than a buck or two.
$hits getting real
And earnings next Thursday......I don’t expect huge earnings, but even a hint of new sales growth will get us back to the high teens.
We’ll hit 10mil today in volume....the beast is awake.
Great find Kash
and here it is ...
My bad, on the lightning round Friday, just saw it.I agree, there’s a lot more room than 3-4 bucks , that is nuts, just today and updated PT of 30, from Wainwright. Sorrento is due any day.
Chet, when , where did Cramer make that statement?
With the FDA backlog and vaccine glut here in the states, this is a much better route for INO, who could never go toe to toe with Pfizer, Moderna and Novavax.